Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-05

FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sun Pharmaceutical's carbidopa-levodopa, updating the regulatory approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • carbidopa-levodopa (carbidopa-levodopa)

Snippet

SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)